POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,354,122 | -26.4% | 952,642 | 0.0% | 1.16% | -14.2% |
Q2 2023 | $8,630,937 | +24.6% | 952,642 | 0.0% | 1.35% | +16.5% |
Q1 2023 | $6,925,707 | -0.3% | 952,642 | 0.0% | 1.16% | -22.4% |
Q4 2022 | $6,944,760 | -14.7% | 952,642 | -9.5% | 1.49% | +31.9% |
Q3 2022 | $8,138,000 | +145.2% | 1,052,842 | +77.7% | 1.13% | +209.6% |
Q4 2021 | $3,319,000 | -41.6% | 592,592 | -19.8% | 0.36% | -23.6% |
Q3 2021 | $5,684,000 | – | 739,190 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
Atom Investors LP | 60,103 | $479,000 | 0.22% |